Why should biomedical scientists care about biodiversity?  by Kelsh, Robert N. et al.
Current Biology Vol 21 No 6
R210
The ecological tradition is different: 
ecologists emphasise the diversity of 
their organisms, and many ecologists 
would argue that their organism is 
‘unique’ because it exhibits adaptations 
to its environment. This uniqueness 
is encapsulated in the Linnaean 
binomial nomenclature: this label, by 
definition, establishes that a group 
of organisms is distinct enough 
from their relatives. Sticking the 
correct label on an organism can be 
important; for instance, the discovery 
that the medicinal leech is not Hirudo 
medicinalis, rather H. verbena [2], 
may lead to new research in natural 
populations of H. medicinalis for 
compounds that are more effective 
anticoagulants, painkillers and  
anti-inflammatory drugs than the 
existing ones.
But conservation biologists are 
also to blame for failing to embrace 
biomedical research. Conservation 
biology focuses on ecological 
processes, and rarely brings in tools, 
approaches and results from the vast 
biomedical literature. This perspective 
is now beginning to change, as 
evidenced by recent reviews 
emphasising the biodiversity resources 
that benefitted biomedical science, and 
the significance of healthy ecosystems 
in hampering spread of pathogens 
and infectious diseases [3,4], and by 
the re-naming of the former Wildlife 
Trust in the United States as the 
EcoHealth Alliance. Biodiversity can 
have immense impact on health, social 
life and finances of humans, and when 
research agencies need to justify their 
spending as being relevant to human 
well-being, the biomedical use of 
plants, microbes and animals is one of 
the underutilised justifications.
Only a fraction of the Earth’s species 
has been named, let alone studied in 
detail. The majority of the undescribed 
organisms comprise the bacteria, 
Achaea, microeukaryotes (fungi, 
nematodes, algae and others) and 
arthropods, many of which could be of 
great practical importance for humans. 
At the present rate of discovery and 
description, however, many species 
will vanish before they are discovered. 
Therefore, biomedical scientists have an 
immense task of joining systematists, 
evolutionary biologists and ecologists 
discovering the processes underpinning 
the tree of life.
There are many reasons why humans 
should care about biodiversity and 
its loss: species and their genes, 
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Biodiversity is now being lost at a rate 
unprecedented in human history and 
this loss, rather than slowing, is most 
likely accelerating [1]. Biomedical 
scientists are aware of biodiversity 
loss, but so far have failed to mobilise 
the full potential of their research skills 
and scientific influence to address the 
issue. This view is poignantly exposed 
by an eminent biomedical scientist who 
asked one of us at a party “we all know 
that species are in trouble, but why 
does this matter?”
There may be two reasons 
why some biomedical scientists 
might think this is a perfectly 
valid question. Firstly, biomedical 
scientists predominantly work with 
model organisms: species that are 
well suited to address a particular 
molecular, cellular, developmental or 
genetic issue, or that can be used to 
understand fundamental physiological 
or health-threatening processes that 
occur in humans and domesticated 
animals. Understandably, if 
someone has a constant supply of 
Caenorhabditis elegans, Drosophila 
melanogaster and Mus musculus, 
then the loss of Yangtze River dolphin 
Lipotes vexillifer, the golden toad 
Incilius periglenes in Costa Rica, or 
the Partula snails in French Polynesia 
does not seem to be of immediate 
concern.
Secondly, by working with model 
organisms in the lab, the research 
of many biomedical scientists is 
detached from nature. Few biomedical 
scientists investigate the organisms 
in their natural habitats, and this 
is important because working 
with a species in nature often 
makes transparent how badly an 
organism’s habitat or its population is 
deteriorating. Without these first-hand 
experiences from wild populations, 
lab-based scientists are easily lured 
into the ‘business as usual’ attitude.
My Word communities and ecosystems provide vital support for humans (with direct 
and indirect economic values), and 
they have immense intrinsic ethical 
and spiritual value [5]. Beyond 
these general justifications, we see 
seven fundamental reasons why 
the biomedical scientist community 
should be more involved in biodiversity 
conservation.
 Resources to study the mechanistic 
bases of evolutionary diversity. How 
much of evolutionary diversity can 
be explained using the candidate 
gene approach based on biomedical 
model systems? With fewer species 
remaining on the planet, we will have 
less understanding. Of course, it 
can be argued that we do not need 
to understand everything; we just 
need to study sufficient examples 
to understand the principles. 
Nevertheless, with the prediction that 
many species may go extinct before 
they have even been described, there 
is an immense risk of losing key, 
informative examples. 
Resources to understand the 
emergence of new human pathogens. 
The importance of anthropologically-
altered ecologies in the emergence of 
new human pathogens is just beginning 
to be recognised [4]. For example, 
the transmission of HIV-1 and Ebola 
viruses to humans, and thus the origin 
of AIDS and Ebola haemorrhagic 
fever, has been linked to the hunting 
of apes and bats as bushmeat [6]. 
Here epidemiology provides a strong 
warning of the risks of the uncontrolled 
and short-sighted exploitation of the 
natural world.
Resources for bioprospecting. 
Species that have never been named 
let alone investigated provide vast 
resources within which to search for 
drugs, protective agents for food 
crops and domesticated animals. 
Bioprospecting is flourishing, and 
by cutting branches off the tree of 
life, we may miss fundamentally new 
solutions to human-focused problems. 
For instance, the denning behaviour 
of certain bear species and the 
associated physiological processes 
suggest this unlikely group as being 
a treasure-trove for finding cures for 
osteoporosis, renal diseases and 
diabetes [3]. Fasting polar bears Ursus 
maritimus are six times more obese 
than any human, yet they show none of 
the symptoms of cardiac diseases. By 
working out the mechanisms by which 
polar bears escape cardiovascular 
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disease, medical science may benefit 
millions of obese people. Uncharted 
species therefore can provide new 
physiological pathways and new drugs, 
although these treasure-troves are 
rapidly shrinking: for instance, eight 
bear species, including the polar bear, 
are red-listed.
The importance of prospecting 
new species for drugs cannot be 
overemphasised; for example, the 
majority (116 out of 158) of new small-
molecule drugs that were licensed in 
the US during the period 1998–2002 
can be traced back to natural origins [3].  
Our current understanding extends 
to only a tiny range of the diverse 
life-styles found in nature. In 
particular, extreme environments 
such as high pressure and cold and 
hot temperatures demand special 
adaptations, and yet we are only 
beginning to name and explore 
physiologically the species that exist 
under these environments (for example, 
in hydrothermal vents [7]).
Resources for identifying new tools 
for biomedical science. Biomedical 
science has been enormously 
enriched for tools by drug discovery 
programmes, including cyclopamine, 
tetracycline, and taxol. Indeed, many 
drug leads that have to be abandoned 
at late stages because of toxicity issues 
nevertheless remain useful as tools for 
dissecting genetic and physiological 
mechanisms. Countless further tools 
doubtless await discovery, if we 
preserve biodiversity long enough  
to screen for them.
Identification of novel approaches to 
medicine. Exploration of biodiversity 
can open up new biomedical 
possibilities. For example, biomedical 
studies confined to mice  
(M. musculus) or humans could have 
resulted in dismissal of the possibility 
of regenerative medicine for many 
purposes, such as limb replacement, 
or spinal cord injuries. But studies of 
other species, especially amphibians 
and fish, have identified substantial 
powers of natural regeneration that 
give hope that regeneration might be 
coaxed out of mammalian tissues [8]. 
Other prospective treatments might 
be revealed by study of non-model 
organisms.
Opportunities for collaborative 
research between ecologists and 
biomedical scientists. Understanding 
the processes by which alien species 
infect and infest natural systems, 
or microbes like the chytrid fungus 
Batrachochytrium dendrobatidis spread 
and kill vast numbers of amphibians, 
need tools and approaches only 
biomedical scientists can provide. 
Epidemiologists, mycologists and 
other biomedical scientists should join 
conservation biologists to combat the 
fungus. As well as the opportunity for a 
new research area, urgent efforts in this 
direction have a further importance for 
biomedical scientists: since amphibians 
harbour potential medicines and 
bioactive peptides and are frequently 
used in studies of embryonic 
development, the likely loss of tens 
of hundreds of amphibian species in 
the near future may hurt advances in 
biomedical science [3,9].
Sources of new research 
opportunities. All the biomedical 
model organisms used so successfully 
today were carefully selected for 
their suitability for studying a specific 
problem. For example, both zebrafish, 
Danio rerio, and the nematode worm, 
Caenorhabditis elegans, were chosen 
initially as having a suite of characters 
making them ideal for understanding 
the development and function of the 
nervous system. This selection resulted 
from comparative studies examining 
diverse candidate organisms for their 
key traits, selected against a list of 
desirable features. The selection of 
model organisms used in current 
biomedical research is understandably 
biased towards organisms that will 
do well in a lab environment — hardy, 
fast breeding, fecund; they may well 
therefore not be the most appropriate 
models to identify candidate genes 
and physiological processes to model 
certain human diseases. 
Some key biological topics are 
not served well by the current model 
species, for instance sociality, vocal 
learning and pair-bonding. To study 
these, new organisms will need to be 
identified and explored. For instance, 
many birds have complex repertoires 
of up to about 1000 songs, and among 
songbirds (Oscines) the songs are 
learnt from conspecifics [10]. Songbirds 
are therefore great model systems 
to work out how and when complex 
vocalisations are learnt, and identify 
the neural substrate that facilitates 
vocal learning. Similarly, small rodents, 
Microtine voles, proved to be great 
systems to reveal the neurogenetics of 
pair bonding and mate preference [10].  
A thorough understanding of the 
Earth’s biomes, and their conservation 
in a healthy state, will be necessary if 
we are to identify organisms best suited 
to these questions.
In conclusion, we urge biomedical 
scientists to engage more in 
biodiversity conservation — for 
the sake of our scientific discipline 
and for the benefit of society. 
Biomedical scientists can make 
crucial contributions to combating 
the loss of diversity and improving 
the health of our planet. Conversely, 
biodiversity offers untapped resources 
for biomedical science. With support 
from the full community of biological 
scientists, conservation initiatives 
will be enriched and the benefits 
our species draws from protected 
biodiversity will be so much greater. 
Given the massive environmental 
problems humankind faces in the 21st 
century, there is an urgent need for joint 
initiatives by biomedical scientists and 
conservation biologists.
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